Ad
related to: skadden arps slate
Search results
Skadden lawyer with ALS is focus of Amazon Prime documentary
Reuters· 4 hours agoIt started in 2017, when Brian Wallach casually mentioned to his doctor that his left hand had been...
US Duo Takes On Merck's $3B Acquisition Of EyeBio | Law.com International
Law.com· 4 days agoSkadden Arps Slate Meagher & Flom and Gibson Dunn & Crutcher have taken on lead roles in New...
Expert Perspectives on Biggest Court Cases
Law.com· 3 hours agoThe line seems to fall from the sky to Brian Wallach. “This is my final closing argument.” Late in the new documentary film For Love & Life: No Ordinary...
3 US Law Firms Act as Energy Capital Partners to Buy Atlantica for $2.6B | Law.com International
Law.com· 5 days agoSkadden Arps Slate Meagher & Flom, Latham & Watkins and Weil Gotshal & Manges are advising on the...
Women of Influence: Attorneys 2024 – Virginia Milstead
Los Angeles Business Journal· 5 days agoVIRGINIA MILSTEAD Partner Skadden, Arps, Slate, Meagher & Flom LLP Virginia Milstead, a partner in...
Pershing Square Holdings Notes the Sale by Pershing Square Capital Management of 10% Common Equity...
Investing.com· 3 hours agoPershing Square Holdings, Ltd. today noted that Pershing Square Capital Management, L.P. (“PSCM”),...
Hong Kong Bankers Get a Boost From Convertible Bond Frenzy
Bloomberg via Yahoo Finance· 3 days ago(Bloomberg) -- When one door closes, another one sometimes opens. For bankers in Hong Kong, where...
Lionsgate Names Brian Weinstein Co-CEO of 3 Arts Entertainment
Next TV via Yahoo Finance· 4 days agoBefore joining Bad Robot, Winstein was head of global client strategy at CAA. Before that he was an...
Krispy Kreme Hires CLO With Sweet-Treat Experience | Corporate Counsel
Law.com· 4 days agoThe doughnut chain Krispy Kreme has tapped former Pfizer legal executive Atiba Adams as chief legal...
Merck to Acquire EyeBio
Morningstar· 5 days agoMerck (NYSE: MRK), known as MSD outside of the United States and Canada, and Eyebiotech Limited (EyeBio), a privately held ophthalmology-focused biotechnology company, today announced that the ...